Recent Blog Articles
Got immunity? Thank your thymus
Easy ways to shop for healthful, cost-conscious foods
When — and how — should you be screened for colon cancer?
7 organs or glands you may do just fine without
How to help your child get the sleep they need
What color is your tongue? What's healthy, what's not?
Immune boosts or busts? From IV drips and detoxes to superfoods
The new RSV shot for babies: What parents need to know
Dealing with thick, discolored toenails
Prostate cancer: A new type of radiation treatment limits risk of side effects
Harvard Health Blog
Read the latest posts from experts at Harvard Health Publishing covering a variety of health topics and perspectives on medical news.
Prostate Health Information
Welcome! This Web site combines prostate cancer news, expert commentary, relevant clinical findings, updates on important prostate cancer research, and personal case histories to help you fully understand the important considerations in the diagnosis and treatment of disorders of the prostate. We hope you find it useful.
Questioning hormone therapy as a primary cancer treatment for older men
Given the possible side effects of hormone therapy, such as bone loss, fractures, diabetes, and heart trouble, clinicians might want to think twice before prescribing hormone therapy as the primary cancer treatment for older men with early-stage disease.
What is prostatic intraepithelial neoplasia (PIN)?
No consensus exists about what type of medical follow-up is in order for this “precancerous” condition or whether to treat it. Marc B. Garnick, M.D., explains the condition and outlines your options.
Experimental drug shows promise against prostate cancer
An experimental drug may halt the production of male hormones in the body, making it a promising treatment for prostate cancer patients whose tumors have not responded to other therapies. Preliminary studies showed shrinking tumors and drops in PSA levels.
No difference between drug and placebo in treating chronic prostatitis
Many urologists prescribe alpha blockers to treat chronic prostatitis, but study shows that one such drug is ineffective in easing the condition.
Investigational vaccine aids patients with metastatic prostate cancer
A new prostate cancer vaccine may give hope to men with metastatic prostate cancer by spurring their immune systems to fight the disease, according to a presentation by Iowa researchers at the American Urological Association’s annual meeting in May 2008. Enabling a patient’s immune system to attack cancer cells can improve quality of life and extend survival.
Data show drug’s benefit in preventing prostate cancer
Despite previous controversy, researchers report that finasteride may reduce overall disease risk and decrease rate of aggressive tumors.
Drug combo may fight prostate cancer
Research shows that combining the anti-inflammatory drug celecoxib (Celebrex) and the cholesterol-lowering statin drug atorvastatin (Lipitor) halted the progression of prostate tumors in mice. Investigators are now planning to test the combo in prostate cancer patients.
Breast cancer genes pose threat to prostate health, too
Research shows that men who carry the BRCA1 and BRCA2 genes are at higher risk of developing prostate cancer than men without the genes.
Testosterone supplements of little benefit in older men
Research has shown that testosterone levels decline as men age. In theory, taking testosterone supplements should counter that natural process. But a Dutch study concluded that they few benefits.
Obesity may affect PSA levels, delay cancer diagnosis
Obese men tend to have lower PSA concentrations than men with healthier weights. As a result, fewer obese men undergo biopsies, potentially leaving prostate cancer undetected.
Hormone therapy for prostate cancer puts heart at risk
A study by Boston researchers found that hormone therapy may increase risk of death from heart disease, especially among patients who have had prostate surgery.
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!